About admin

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam viverra euismod odio, gravida pellentesque urna varius vitae. Sed dui lorem, adipiscing in adipiscing et, interdum nec metus. Mauris ultricies, justo eu convallis placerat, felis enim ornare nisi, vitae mattis nulla anti dui.

Thursday January 5th, 2017

Launch of the VisioCyt1 clinical trial

Thursday January 5th, 2017|

VitaDX launches today its first clinical trial VisioCyt 1. This multicentric study on 1300 patients aims to evaluate the diagnostic performances of the VisioCyt® test.

Tuesday December 20th, 2016

Wednesday November 23rd, 2016


Wednesday November 23rd, 2016|

VitaDX and EVOSCIENCES enter into a partnership to facilitate access to the equipment required for the implementation of the VisioCyt® solution.

Friday April 1st, 2016

Monday February 1st, 2016


Monday February 1st, 2016|

Making Bladder Cancer Cells Glow earns French Biotech €1.5M

Friday January 15th, 2016

Friday January 1st, 2016

Thursday October 1st, 2015

Rennes Atalante

Thursday October 1st, 2015|

The former President of Vitalitec becomes Chairman of the Board of VitaDX

Tuesday September 1st, 2015

Monday June 1st, 2015

SATT Paris-Saclay

Monday June 1st, 2015|

The SATT Paris-Saclay supports the VitaDX start-up to develop a promising new technique for early cancer diagnosis, resulting from joint research between the ONERA (French Aerospace Lab), CNRS (French Centre for Scientific Research), Paris Hospitals (AP-HP) and the University of South-Paris.